Study origin and published date |
Study design and author |
Study population and sample size |
Inferences |
Canada, April 2020 |
Post-hoc analysis of data from a prospective cohort study, Beaubien-Souligny et al. [34] |
Patients who are 18 years or older, not critically ill, and undergoing cardiopulmonary bypass, 145 |
By using a variety of POCUS markers, it is possible to identify venous congestion that is clinically significant. If severe flow abnormalities are present in multiple Doppler patterns along with an enlarged IVC (≥2 cm), it is considered severe venous congestion. This condition is strongly associated with the development of AKI in the future |
West Indies, December 2021 |
Case report, Singh et al. [35] |
A case of dilated cardiomyopathy with systemic venous congestion undergoing non-cardiac surgery. |
VExUS identify organ congestion, which can help heart failure patients. This information guides decongestive therapy and reduces the risk of postoperative complications |
Spain, February 2023 |
Prospective cohort, Torres-Arrese et al. [36] |
AHF patients, 74 |
On admission, mortality can be predicted by intra-renal venous Doppler assessment, VExUS score, and pulsatility over 50%. An IVC larger than 2 cm and an intra-renal monophasic pattern can accurately predict the risk of re-admission |
India, September 2020 |
Prospective cohort, Bhardwaj et al. [37] |
Patients with cardiorenal syndrome, 30 |
Combined evaluation of IVC, hepatic vein, and portal vein grading could be a reliable way to display venous congestion and help guide the decision to remove the fluid |
Mexico, Jan 2021 |
Case series, Argaiz et al. [38] |
Patients with ADHF, 12 |
Using POCUS to assess abdominal venous congestion can assist in identifying and monitoring patients with congestive kidney injury and guide decongestive therapy in patients with ADHF |
United States, May 2023 |
Prospective observational study, Longino et al. [39] |
Patients undergoing right heart catheterization, 56 |
A significant connection is present between VExUS and RAP across a range of patients, providing evidence for further exploration of VExUS to evaluate venous congestion and direct treatment for various critical conditions |